Although Retatrutide is not yet available, those interested in weight loss can still benefit from alternative treatments offered by Klinic's partners

Try the BMI Calculator Mechanical unloading: Significant weight loss directly reduces force on weight-bearing joints, which is the single most impactful intervention for knee and hip osteoarthritis Inflammatory cytokine reduction: Lower levels of IL-6, TNF-alpha, and CRP reduce the inflammatory signals that drive cartilage degradation and joint swelling Adipokine normalization: Weight loss reduces leptin and resistin levels, both of which promote cartilage destruction and synovial inflammation when improved Improved physical function: Patients who lose substantial weight are better able to engage in physical therapy and exercise, which strengthens the muscles that support and stabilize joints Metabolic comorbidity improvement: Better blood sugar control and reduced insulin resistance may independently lower inflammatory arthritis activity Important Safety Information Tirzepatide is a prescription medication with known side effects
Drug Metabolism and Disposition, 52(9), 1000-1012
Some comparative data suggests tirzepatide may have modestly lower nausea rates, though direct head-to-head trials are limited
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials